Autophagy, a cellular recycling process, is repressed during cell division to protect the genome. The researchers identified CDK1 as the key regulator of this repression, decoupling conditional control and halting autophagy until the cell division process is complete.
Researchers have discovered that autophagy activity is essential to maintain high mTORC1 activity in cells with mutated genes, and blocking this process can mimic human TSC symptoms. This finding holds promise for developing new therapeutic concepts for treating patients with this devastating disease.
Researchers found that beta-blockers can cause psoriasis by interfering with the breakdown of defective cell components and disrupting autophagy. This leads to the release of inflammatory messengers, resulting in skin problems. The study suggests that fat-soluble beta-blockers are more likely to cause inflammation.
A research team has identified a novel caloric restriction mimetic, 3,4-dimethoxychalcone, which induces autophagy and promotes longevity. The substance may prove useful in treating age-related diseases such as cardiovascular disease and cancer.
A new study has shed light on the mechanisms behind autophagy, a process that helps destroy bacteria and viruses. The research suggests that faulty autophagy can contribute to neurodegenerative diseases like dementia, and that targeting a specific protein interaction may lead to new treatments.
Researchers found that chronic stress leads to autophagic death of adult hippocampal NSCs, causing decline in adult neurogenesis. Deleting Atg7 or SGK3 gene prevents cell death and maintains normal brain functions.
Researchers found that deregulated mTOR leads to decreased autophagy, causing accumulation of damaged organelles and promoting crystal-cell interactions. An mTOR inhibitor alleviates these effects, suggesting that targeting this pathway may prevent or treat kidney stones.
Scientists at WashU Medicine have found a set of genes that help cells survive exposure to cytokines, which can trigger a deadly cytokine storm. Targeting these genes may lead to new treatments for sepsis, a life-threatening condition that claims 15% of patients despite prompt medical care.
As cells age, their ability to remove damaged proteins and structures declines, leading to a buildup of waste inside neurons. Researchers discovered that restoring autophagy in aged neurons can restore protein disposal, providing insight into potential therapeutic targets for neurodegenerative diseases.
Research found that ATG7 is related to the onset of frontotemporal dementia and Lou Gehrig's disease. The study showed that activating autophagy through ATG7 can improve neurodegenerative symptoms in fruit flies, suggesting a potential treatment for neuro-degenerative diseases.
Researchers found that autophagy in dendritic cells supports T-cell anticancer activity by regulating receptor CD36. This process enhances the phagocytosis of apoptotic tumor cells while restricting T-cell activation.
Researchers found that autophagy helps build and break down plant oils by delivering fatty acids from membrane recycling to lipid droplets. By manipulating this process, scientists may be able to drive up oil accumulation in bioenergy crops.
Scientists found that disrupted autophagy leads to protein accumulation, causing neuronal communication problems and behavioral changes resembling human autism spectrum disorder (ASD) and schizophrenia. The study confirms a link between mTOR-autophagy and GABA signaling in the development of social behavior deficits.
Researchers at Washington University in St. Louis have identified a new structural feature of living cells that aids in tidying up defective cellular material, implicated in disorders such as Huntington's and Alzheimer's diseases. The discovery could lead to new preventive or therapeutic targets for human disease.
Researchers at MGH found that mitochondrial permeability determines the impact of autophagy on lifespan, with low levels required for health benefits. Elevated autophagy can be detrimental due to excessive opening of the mitochondrial permeability transition pore.
Researchers found that host cells use autophagy to target specific bacterial proteins for recycling, which could be used by bacteria to escape clearance. Enhancing autophagy through activators may help fight bacterial infections and develop new therapies.
Researchers at UNC Lineberger Comprehensive Cancer Center have made a promising discovery in treating pancreatic cancer by making cells reliant on autophagy, a process of cellular recycling. A novel treatment strategy combining an autophagy inhibitor with another compound has shown increased efficacy in laboratory studies.
A collaborative study improves understanding of ALS by identifying a key role for ubiquilin proteins in regulating cellular waste. The researchers found that mutated ubiquilins fail to regulate lysosomes, leading to excess waste buildup and disease development.
A recent study by Osaka University found that increased expression of Rubicon in tissues from aged animals contributed to reduced levels of autophagy. This reduction in autophagy may lead to progression of aging and diseases. Suppression of Rubicon led to improved age-related factors and increased lifespan in worm and fly models.
Monash researchers found that autophagy receptors are not the main trigger for cellular cleanup, but rather the membranes themselves recruit more receptors to speed up the process. This discovery may lead to new treatments targeting protein build-up linked to neurodegenerative diseases.
A study by Salk researchers found that autophagy, a process thought to be a survival mechanism, actually promotes cell death and prevents cancer initiation. This discovery reveals autophagy as a novel tumor-suppressing pathway and challenges the conventional understanding of cancer development.
Research suggests that autophagy on neuronal cells can lead to neurodegeneration, highlighting the importance of targeting mitochondria and autophagy-related proteins in disease treatment. Mitochondrial dysfunction is a significant contributor to neurodegenerative diseases, such as Alzheimer
Researchers at Tokyo Institute of Technology discovered the role of Atg2 in tethering pre-autophagosomal membranes to the endoplasmic reticulum. The study found that Atg2's N- and C-terminal regions have membrane-binding capabilities, allowing it to initiate autophagosome formation and expand membranes. Understanding this mechanism is ...
C3 regulates autophagy in beta cells, enabling protection from stress and potentially treating diseases like type 2 diabetes. Disruption of this mechanism can contribute to disease development.
A team of researchers investigated influenza A's impact on lung-derived cell lines, discovering that the virus alters protein levels and locations. The study found that many proteins are relocalized, with viral and ribosomal proteins increasing in autophagosomes.
Researchers found that exercise stimulates autophagy, a cellular process responsible for removing damaged proteins and toxins from muscles. The study shows that regular physical activity can reduce the buildup of toxic proteins in muscles, leading to improved muscle function and reduced wasting.
A study by researchers at the University of Cincinnati found that cell metabolism significantly influences autophagy, a survival program used by some tumor cells to evade treatment. The findings suggest that manipulating this pathway could lead to better cancer treatments and outcomes.
A direct link has been discovered between protein aggregation in nerve cells and the regulation of gene expression in Huntington's disease. The study found that impaired autophagy leads to accumulation of misfolded proteins, including AGO2, which disrupts cell function and signal pathways.
A University of Colorado Cancer Center study reveals that inhibiting the action of lysosomes can efficiently kill metastatic cancer cells. Researchers found that the level of a protein called ID4 predicts which cancer patients will benefit most from treatment with chloroquine.
Researchers have gained new understanding of how autophagosomes seal off waste material, with a key role identified for ESCRT complexes. This breakthrough could lead to new cancer treatments by inhibiting autophagy closure.
Researchers have identified three known SNAREs and a new protein Ykt6 as essential for the fusion of autophagosomes with vacuoles, allowing for efficient cellular waste recycling. This breakthrough study sheds light on the molecular mechanisms underlying autophagy, a vital process in maintaining cellular homeostasis.
Researchers found that autophagy efficiency declines with age, leading to accumulation of damaged biological structures in the kidneys. They discovered that nutrition restrictions and pharmacological drugs like rapamycin may help tackle this issue.
The NSU research team aims to improve therapeutic cell efficiency through manipulation of autophagy, a self-digestion pathway affecting exosome content. Understanding this process can lead to faster wound healing and improved organ regeneration.
Researchers have discovered peptides that can inhibit autophagy in living animals, providing a promising treatment against various diseases. The peptides are derived from giant ankyrins and can be used to occlude autophagy spatiotemporally.
Researchers at UT Southwestern found that mice with increased autophagy levels live longer, healthier lives, with a 10% extension in lifespan. The study also shows protection against age-related cancers and diseases.
Brown University researchers found a new strategy to stimulate autophagy, the cellular recycling process, by manipulating a transcription factor. The approach increased lifespans of worms and flies, and hinted at potential treatments for Alzheimer's disease and ALS in human cells.
Researchers have identified a novel regulatory step in autophagy, shedding light on the anti-cancer potential of PI5P4K inhibitors. Targeting these proteins could be a promising approach for cancer therapeutics.
Diabetes impairs autophagy, a protective mechanism that filters blood waste, worsening prognosis and destroying kidneys. Researchers focus on restoring autophagy to find new therapies for acute kidney injury.
Resistance training increases autophagosome content in young men's muscles, but this effect may be reduced by aging. The study found that UPR is activated by resistance exercise regardless of age, suggesting similar muscle adaptation between young and older individuals.
The Protein Society has awarded Minfei Su and Chang-Ting Lin the 'Best Paper' award for their research on autophagy, a critical process in eukaryotic cells. The winners' work investigates the structural and thermodynamic details of protein interactions, shedding light on cellular homeostasis and evolution.
Researchers discovered that inhibiting autophagy with the help of FOXO3a molecule can push cancer cells into apoptosis. The study found that combining autophagy inhibition with a drug called Nutlin increases PUMA production, leading to cell death.
Researchers at Tohoku University discovered that plants activate autophagy in leaf cells to derive essential amino acids during periods of low sunlight. This process allows plants to survive and grow under conditions of energy scarcity, enabling them to adapt to environmental challenges.
Researchers at Tokyo Medical and Dental University develop a new system to visualize ubiquitin assembly in real time, revealing new insights into the molecular details of autophagy. The technique allows for the study of previously unexplored residues involved in forming ubiquitin chains.
Researchers studying a rare genetic disorder in children have discovered insights into biological mechanisms that drive the disease, including abnormal autophagy. They also identified a urine test as a biomarker for the disorder, which may help monitor response to treatment and develop precision medicine.
Researchers developed a technique to visualize mitophagy, the process by which cells recycle their energy factories, with a new bioimaging technology. The study could provide diagnostic information for degenerative brain diseases.
Researchers found FOXO proteins maintain healthy cartilage and prevent joint degeneration. Targeting FoxO could develop new therapies to treat osteoarthritis.
Researchers found that impairing Paneth cells allows gut bacteria to invade the small intestine, causing major inflammation. Normal autophagy in Paneth cells is required to regulate bacteria, keeping it at bay and preventing disease.
Researchers at Newcastle University found that a small adaptation in the protein p62 helps cells respond to stress and activate autophagy, a process that removes damaged components from cells. This discovery could help explain why humans have increased natural defenses and longer lifespans compared to other organisms.
Researchers found that autophagy proteins are responsible for triggering autoimmune processes in a mouse model of multiple sclerosis. Genetic switch-off of ATG5 protein reduced pathological T cell levels and inflammation in the central nervous system, suggesting its role in disease progression.
Researchers at King's College London have discovered novel mechanisms of cell death involved in debilitating neurodegenerative disorders like Alzheimer's disease and Parkinson's disease. This finding could lead to new treatments or delay the progression of currently incurable conditions.
Researchers found that inhibiting autophagy in tumor cells increases the production of CCL5, a cytokine that attracts NK cells. This leads to a significant reduction in tumor size and improved survival rates for melanoma patients.
Researchers at the University of Warwick have discovered a link between inflammation and autophagy, a cellular process that breaks down harmful elements. This understanding could lead to more effective treatments for gut diseases like colon cancer, Crohn's, and ulcerative colitis.
A new molecular pathway controlling lifespan and healthspan has been identified in worms and mammals. Excess levels of proteins called Kruppel-like transcription factors (KLFs) can extend lifespan and improve blood vessel function, highlighting a potential target for age-related diseases.
Researchers found that low dietary potassium promotes elevated aortic stiffness, while increased dietary potassium alleviates it. Increased potassium also reduced vascular calcification and aortic stiffness in mouse models, suggesting its potential to protect against heart disease.
Researchers have identified genes promoting health and fitness in young worms but driving aging later in life. This discovery may have implications for treating neurodegenerative disorders like Alzheimer's and Parkinson's diseases.
Researchers discovered that autophagy, a cellular 'clean-up process', initially slows ALS disease progression but later accelerates its deadly spread through the spinal cord. The study provides new insights into the complex mechanisms of ALS and lays the groundwork for therapies that could eventually prevent its onset.
Researchers at The Wistar Institute have established a correlation between the Wnt signaling pathway and a novel class of autophagy inhibitors in melanoma therapy. High levels of Wnt5A expression are linked to increased autophagy activation, making cells less sensitive to autophagy inhibition.
Recent research from NTNU found that omega-3 fatty acids can dampen harmful inflammatory reactions in the body, particularly by activating autophagy and inhibiting interferon response factors. This may be beneficial for patients with conditions driven or aggravated by strong inflammatory responses.
Researchers from Florida Atlantic University discover that autophagy, a garbage disposal-like process, combined with food absorption and smell influences aging. Smelling food enhances lifespan by 20% in C. elegans worms on restricted diets.
Researchers at the Francis Crick Institute have uncovered a pathway controlling autophagy, a process that eliminates diseased cell parts. This finding may help prevent diseases like Alzheimer's and Parkinson's by targeting the disposal system.